Matthew P. Kowalsky
Directeur Administratif chez SIGILON THERAPEUTICS, INC.
Fortune : - $ au 31/07/2023
Profil
Matthew P.
Kowalsky is currently the Secretary & Chief Legal Officer at Sigilon Therapeutics, Inc. and the Chief Legal Officer at Enanta Pharmaceuticals, Inc. Previously, he worked as the Assistant General Counsel at ARIAD Pharmaceuticals, Inc., the Associate General Counsel at Cubist Pharmaceuticals LLC, the Senior Corporate Counsel at Genzyme Corp., the Secretary & Vice President-Legal at Proteon Therapeutics, Inc., and the Assistant General Counsel at Lantheus Medical Imaging, Inc. He obtained his undergraduate degree from the University of Notre Dame and his graduate degree from the University of Notre Dame The Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/08/2023 | 0 ( -.--% ) | - $ | 31/07/2023 |
Postes actifs de Matthew P. Kowalsky
| Sociétés | Poste | Début |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Directeur Administratif | - |
| ENANTA PHARMACEUTICALS, INC. | Conseiller Juridique Général | 30/04/2024 |
Anciens postes connus de Matthew P. Kowalsky
| Sociétés | Poste | Fin |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Conseiller Juridique Général | 01/01/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/05/2016 |
| CUBIST PHARMACEUTICALS INC | Conseiller Juridique Général | 01/01/2015 |
| ARIAD PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/11/2013 |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Conseiller Juridique Général | 01/01/2013 |
Formation de Matthew P. Kowalsky
| University of Notre Dame | Undergraduate Degree |
| University of Notre Dame The Law School | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
